US Stock MarketDetailed Quotes

LFCR Lifecore Biomedical

Watchlist
  • 7.620
  • +0.960+14.41%
Close Jan 3 16:00 ET
  • 7.620
  • 0.0000.00%
Post 20:01 ET
282.13MMarket Cap-14.11P/E (TTM)

Lifecore Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Nov 24, 2024
(Q1)Aug 25, 2024
(FY)May 26, 2024
(Q4)May 26, 2024
(Q3)Feb 25, 2024
(Q2)Nov 26, 2023
(Q1)Aug 27, 2023
(FY)May 28, 2023
(Q4)May 28, 2023
(Q3)Feb 26, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-574.38%-6.11M
92.28%-643K
98.76%-217K
481.96%8.64M
84.51%-1.82M
154.74%1.29M
-656.49%-8.33M
22.80%-17.44M
-312.77%-2.26M
33.90%-11.73M
Net income from continuing operations
-146.22%-6.57M
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
1.93%-10.75M
14.70%-99.56M
29.34%-39.28M
-176.61%-36.51M
Operating gains losses
94.43%-1.15M
-350.00%-900K
-192.57%-39.48M
-90.04%2.4M
-201.74%-21M
-94,104.55%-20.68M
90.51%-200K
651.86%42.65M
9,424.90%24.1M
275.97%20.64M
Depreciation and amortization
15.74%2.04M
-8.07%1.99M
-32.77%8.86M
-15.66%2.25M
-16.81%2.67M
-39.93%1.77M
-50.21%2.17M
-27.04%13.18M
-25.27%2.67M
-8.95%3.21M
Deferred tax
372.50%109K
-231.58%-100K
-54.34%163K
-121.33%-64K
172.86%191K
-1,100.00%-40K
547.06%76K
105.23%357K
122.16%300K
113.78%70K
Other non cash items
35.15%4.92M
55.85%4.72M
1,360.34%15.61M
540.70%6.2M
18,160.00%2.74M
3,401.92%3.64M
16,922.22%3.03M
350.94%1.07M
749.12%968K
103.50%15K
Change In working capital
-1,200.76%-8.7M
277.74%7.47M
-119.43%-3.85M
-36.84%4.55M
-773.78%-4.99M
-84.12%790K
-161.16%-4.2M
738.21%19.79M
26.22%7.21M
105.67%740K
-Change in receivables
-39.49%-5.02M
152.26%6.02M
-122.10%-2.39M
-94.36%106K
63.67%-1.29M
-168.60%-3.6M
-67.04%2.39M
276.34%10.82M
35.62%1.88M
70.66%-3.54M
-Change in inventory
895.08%2.43M
-95.88%-1.66M
105.82%862K
-958.33%-309K
133.69%1.78M
102.01%244K
-132.82%-849K
-579.40%-14.81M
-99.63%36K
-146.31%-5.27M
-Change in prepaid assets
----
89.94%-244K
----
----
----
----
-228.28%-2.43M
----
----
-273.81%-584K
-Change in payables and accrued expense
-264.19%-4.4M
195.54%3.66M
-129.05%-4.52M
115.29%376K
-98.19%148K
-110.12%-1.21M
-82.34%-3.83M
162.42%15.55M
55.18%-2.46M
4,214.81%8.16M
-Change in other current assets
----
----
10.39%2.38M
----
----
----
----
412.92%2.16M
----
----
-Change in other current liabilities
-343.09%-1.09M
145.61%1.15M
----
----
----
---246K
---2.53M
----
----
----
-Change in other working capital
-75.39%283K
-147.85%-1.46M
-102.95%-179K
-16.32%3.59M
-502.17%-7.96M
1,697.22%1.15M
2,728.45%3.05M
33,855.56%6.08M
730.00%4.28M
213.29%1.98M
Cash from discontinued investing activities
Operating cash flow
-574.38%-6.11M
92.28%-643K
98.76%-217K
481.96%8.64M
84.51%-1.82M
154.74%1.29M
-656.49%-8.33M
22.80%-17.44M
-312.77%-2.26M
33.90%-11.73M
Investing cash flow
Cash flow from continuing investing activities
42.03%-2.47M
32.88%-3.39M
-272.50%-17.92M
57.25%-2.64M
-209.91%-5.97M
-10.73%-4.26M
-2,136.28%-5.05M
-106.02%-4.81M
67.20%-6.17M
-91.72%5.43M
Net PPE purchase and sale
42.03%-2.47M
32.88%-3.39M
16.58%-17.92M
63.24%-2.64M
15.93%-5.97M
-10.73%-4.26M
-50.37%-5.05M
25.41%-21.48M
36.84%-7.17M
-28.74%-7.1M
Net business purchase and sale
----
----
--0
--0
----
----
----
-77.32%16.67M
102.23%1.01M
-89.43%12.53M
Net investment purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Investing cash flow
42.03%-2.47M
32.88%-3.39M
-272.50%-17.92M
57.25%-2.64M
-209.91%-5.97M
-10.73%-4.26M
-2,136.28%-5.05M
-106.02%-4.81M
67.20%-6.17M
-91.72%5.43M
Financing cash flow
Cash flow from continuing financing activities
611.23%12.52M
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
-24.88%2.93M
169.62%39.7M
28.36%24.57M
105.13%2.41M
Net issuance payments of debt
-349.10%-10.94M
-25.45%1.68M
-11.96%2.75M
-99.54%125K
108.83%2.8M
-161.66%-2.44M
-43.24%2.26M
105.63%3.12M
34.32%26.95M
32.51%-31.76M
Net common stock issuance
----
----
--0
----
----
----
----
--4.82M
----
----
Net preferred stock issuance
----
----
--0
--0
----
----
----
--38.08M
--0
----
Proceeds from stock option exercised by employees
-1,610.53%-975K
-99.86%1K
--724K
--0
--57K
---57K
--724K
--0
---4.82M
----
Net other financing activities
----
-1,208.89%-589K
163.85%4.04M
68.96%-739K
----
----
32.84%-45K
-292.80%-6.32M
-157.96%-2.38M
-8,583.72%-3.73M
Cash from discontinued financing activities
Financing cash flow
611.23%12.52M
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
-24.88%2.93M
169.62%39.7M
28.36%24.57M
105.13%2.41M
Net cash flow
Beginning cash position
-36.13%5.52M
-55.68%8.46M
1,061.96%19.09M
4.17%3.07M
-52.84%3.22M
104.69%8.64M
1,061.96%19.09M
26.87%1.64M
59.12%2.95M
526.03%6.83M
Current changes in cash
172.59%3.94M
71.84%-2.94M
-160.92%-10.63M
-66.61%5.39M
96.19%-148K
-307.86%-5.42M
-505.16%-10.45M
4,913.79%17.45M
7,749.76%16.14M
-608.52%-3.88M
End cash Position
193.54%9.46M
-36.13%5.52M
-55.68%8.46M
-55.68%8.46M
4.17%3.07M
-52.84%3.22M
104.69%8.64M
1,061.96%19.09M
1,061.96%19.09M
59.12%2.95M
Free cash flow
-188.60%-8.58M
69.85%-4.04M
53.40%-18.14M
163.62%6M
58.65%-7.79M
52.06%-2.97M
-199.93%-13.38M
25.91%-38.92M
21.04%-9.44M
19.09%-18.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Nov 24, 2024(Q1)Aug 25, 2024(FY)May 26, 2024(Q4)May 26, 2024(Q3)Feb 25, 2024(Q2)Nov 26, 2023(Q1)Aug 27, 2023(FY)May 28, 2023(Q4)May 28, 2023(Q3)Feb 26, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -574.38%-6.11M92.28%-643K98.76%-217K481.96%8.64M84.51%-1.82M154.74%1.29M-656.49%-8.33M22.80%-17.44M-312.77%-2.26M33.90%-11.73M
Net income from continuing operations -146.22%-6.57M-50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M1.93%-10.75M14.70%-99.56M29.34%-39.28M-176.61%-36.51M
Operating gains losses 94.43%-1.15M-350.00%-900K-192.57%-39.48M-90.04%2.4M-201.74%-21M-94,104.55%-20.68M90.51%-200K651.86%42.65M9,424.90%24.1M275.97%20.64M
Depreciation and amortization 15.74%2.04M-8.07%1.99M-32.77%8.86M-15.66%2.25M-16.81%2.67M-39.93%1.77M-50.21%2.17M-27.04%13.18M-25.27%2.67M-8.95%3.21M
Deferred tax 372.50%109K-231.58%-100K-54.34%163K-121.33%-64K172.86%191K-1,100.00%-40K547.06%76K105.23%357K122.16%300K113.78%70K
Other non cash items 35.15%4.92M55.85%4.72M1,360.34%15.61M540.70%6.2M18,160.00%2.74M3,401.92%3.64M16,922.22%3.03M350.94%1.07M749.12%968K103.50%15K
Change In working capital -1,200.76%-8.7M277.74%7.47M-119.43%-3.85M-36.84%4.55M-773.78%-4.99M-84.12%790K-161.16%-4.2M738.21%19.79M26.22%7.21M105.67%740K
-Change in receivables -39.49%-5.02M152.26%6.02M-122.10%-2.39M-94.36%106K63.67%-1.29M-168.60%-3.6M-67.04%2.39M276.34%10.82M35.62%1.88M70.66%-3.54M
-Change in inventory 895.08%2.43M-95.88%-1.66M105.82%862K-958.33%-309K133.69%1.78M102.01%244K-132.82%-849K-579.40%-14.81M-99.63%36K-146.31%-5.27M
-Change in prepaid assets ----89.94%-244K-----------------228.28%-2.43M---------273.81%-584K
-Change in payables and accrued expense -264.19%-4.4M195.54%3.66M-129.05%-4.52M115.29%376K-98.19%148K-110.12%-1.21M-82.34%-3.83M162.42%15.55M55.18%-2.46M4,214.81%8.16M
-Change in other current assets --------10.39%2.38M----------------412.92%2.16M--------
-Change in other current liabilities -343.09%-1.09M145.61%1.15M---------------246K---2.53M------------
-Change in other working capital -75.39%283K-147.85%-1.46M-102.95%-179K-16.32%3.59M-502.17%-7.96M1,697.22%1.15M2,728.45%3.05M33,855.56%6.08M730.00%4.28M213.29%1.98M
Cash from discontinued investing activities
Operating cash flow -574.38%-6.11M92.28%-643K98.76%-217K481.96%8.64M84.51%-1.82M154.74%1.29M-656.49%-8.33M22.80%-17.44M-312.77%-2.26M33.90%-11.73M
Investing cash flow
Cash flow from continuing investing activities 42.03%-2.47M32.88%-3.39M-272.50%-17.92M57.25%-2.64M-209.91%-5.97M-10.73%-4.26M-2,136.28%-5.05M-106.02%-4.81M67.20%-6.17M-91.72%5.43M
Net PPE purchase and sale 42.03%-2.47M32.88%-3.39M16.58%-17.92M63.24%-2.64M15.93%-5.97M-10.73%-4.26M-50.37%-5.05M25.41%-21.48M36.84%-7.17M-28.74%-7.1M
Net business purchase and sale ----------0--0-------------77.32%16.67M102.23%1.01M-89.43%12.53M
Net investment purchase and sale ----------0------------------0--------
Cash from discontinued investing activities
Investing cash flow 42.03%-2.47M32.88%-3.39M-272.50%-17.92M57.25%-2.64M-209.91%-5.97M-10.73%-4.26M-2,136.28%-5.05M-106.02%-4.81M67.20%-6.17M-91.72%5.43M
Financing cash flow
Cash flow from continuing financing activities 611.23%12.52M-62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M-24.88%2.93M169.62%39.7M28.36%24.57M105.13%2.41M
Net issuance payments of debt -349.10%-10.94M-25.45%1.68M-11.96%2.75M-99.54%125K108.83%2.8M-161.66%-2.44M-43.24%2.26M105.63%3.12M34.32%26.95M32.51%-31.76M
Net common stock issuance ----------0------------------4.82M--------
Net preferred stock issuance ----------0--0--------------38.08M--0----
Proceeds from stock option exercised by employees -1,610.53%-975K-99.86%1K--724K--0--57K---57K--724K--0---4.82M----
Net other financing activities -----1,208.89%-589K163.85%4.04M68.96%-739K--------32.84%-45K-292.80%-6.32M-157.96%-2.38M-8,583.72%-3.73M
Cash from discontinued financing activities
Financing cash flow 611.23%12.52M-62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M-24.88%2.93M169.62%39.7M28.36%24.57M105.13%2.41M
Net cash flow
Beginning cash position -36.13%5.52M-55.68%8.46M1,061.96%19.09M4.17%3.07M-52.84%3.22M104.69%8.64M1,061.96%19.09M26.87%1.64M59.12%2.95M526.03%6.83M
Current changes in cash 172.59%3.94M71.84%-2.94M-160.92%-10.63M-66.61%5.39M96.19%-148K-307.86%-5.42M-505.16%-10.45M4,913.79%17.45M7,749.76%16.14M-608.52%-3.88M
End cash Position 193.54%9.46M-36.13%5.52M-55.68%8.46M-55.68%8.46M4.17%3.07M-52.84%3.22M104.69%8.64M1,061.96%19.09M1,061.96%19.09M59.12%2.95M
Free cash flow -188.60%-8.58M69.85%-4.04M53.40%-18.14M163.62%6M58.65%-7.79M52.06%-2.97M-199.93%-13.38M25.91%-38.92M21.04%-9.44M19.09%-18.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday+1.19%